How the protein ETV1 in amygdala support cells may influence fear and anxiety
Control of ETV1 transcriptional networks in amygdalar astrocytes
['FUNDING_R01'] · BRIGHAM AND WOMEN'S HOSPITAL · NIH-11235126
This project looks at whether ETV1 in amygdala astrocytes changes inflammatory signals and nerve activity that can drive fear and anxiety.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BRIGHAM AND WOMEN'S HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11235126 on ClinicalTrials.gov |
What this research studies
The team uses a new lab method (SPEAC-seq) that pairs individual brain support cells, like astrocytes and microglia, inside tiny droplets so they can read how the cells communicate. They will alter the ETV1 gene in astrocytes from the amygdala and measure changes in inflammatory signals and downstream effects on nearby neurons. Most experiments are done in laboratory samples and model brain tissue to map which genes and pathways control immune signals linked to heightened fear responses. The findings will build a detailed map of cell interactions that could point to future therapeutic targets.
Who could benefit from this research
Good fit: People with anxiety disorders—particularly those thought to have inflammation-related symptoms—would be the likely candidates for any future clinical trials based on this work.
Not a fit: Patients seeking immediate treatments or those whose anxiety is clearly unrelated to inflammatory brain processes are unlikely to benefit directly from this basic laboratory research.
Why it matters
Potential benefit: If successful, this work could reveal molecular targets to reduce inflammation-driven overactivity in the amygdala and guide new treatments for anxiety disorders.
How similar studies have performed: Prior animal studies have linked glial inflammation to fear-related behavior, but the SPEAC-seq screening approach and the specific focus on ETV1 are novel and have not yet been tested in humans.
Where this research is happening
BOSTON, UNITED STATES
- BRIGHAM AND WOMEN'S HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WHEELER, MICHAEL ALEX — BRIGHAM AND WOMEN'S HOSPITAL
- Study coordinator: WHEELER, MICHAEL ALEX
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.